España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
MediPharm Labs
MEDIF
OTCQB
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.0479
0.00090
1.91%
At close: -
Get Report
Comment
MediPharm Labs (MEDIF) Forecast
News
Earnings
MediPharm Labs (MEDIF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for MediPharm Labs (OTC:MEDIF) Stock
MediPharm Labs Stock (OTC: MEDIF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
Jelena Martinovic
Wednesday, August 14, 2024
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
Jelena Martinovic
Friday, August 09, 2024
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
Jelena Martinovic
Wednesday, July 03, 2024
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
Jelena Martinovic
Thursday, June 20, 2024
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Jelena Martinovic
Wednesday, May 15, 2024
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
Nina Zdinjak
Wednesday, March 27, 2024
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
Jelena Martinovic
Wednesday, February 07, 2024
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
Jelena Martinovic
Friday, December 22, 2023
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
Jelena Martinovic
Tuesday, November 14, 2023
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
Joana Scopel
Monday, October 16, 2023
New Cannabis Products Energize Global Health & Wellness Market, Including Australia
Joana Scopel
Monday, October 02, 2023
MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M
Nina Zdinjak
Thursday, September 28, 2023
New CBD & THC Cannabis Oils Now Shipping To Australia From Canada
Jelena Martinovic
Wednesday, September 20, 2023
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
Jelena Martinovic
Thursday, August 31, 2023
Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found
Jelena Martinovic
Thursday, August 24, 2023
Cannabis Stock Gainers And Losers From August 24, 2023
Benzinga Insights
Wednesday, August 23, 2023
Marijuana Stock Movers For August 23, 2023
Benzinga Insights
Wednesday, August 16, 2023
Cannabis Stock Gainers And Losers From August 16, 2023
Benzinga Insights
Tuesday, August 15, 2023
Marijuana Stock Movers For August 15, 2023
Benzinga Insights
Monday, August 14, 2023
Cannabis Stock Gainers And Losers From August 14, 2023
Benzinga Insights
Cannabinoid-Focused Pharma Stock Slides On Q2 Earnings Report, Here Are The Details
Nina Zdinjak
Friday, August 11, 2023
Cannabis Stock Gainers And Losers From August 11, 2023
Benzinga Insights
Thursday, August 10, 2023
Cannabis Stock Movers For August 10, 2023
Benzinga Insights
Wednesday, August 09, 2023
Marijuana Stock Movers For August 9, 2023
Benzinga Insights
Tuesday, August 08, 2023
Marijuana Stock Movers For August 8, 2023
Benzinga Insights
Monday, August 07, 2023
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
Benzinga Insights
Friday, August 04, 2023
Cannabis Stock Gainers And Losers From August 4, 2023
Benzinga Insights
Thursday, August 03, 2023
Cannabis Stock Movers For August 3, 2023
Benzinga Insights
Wednesday, August 02, 2023
Marijuana Stock Movers For August 2, 2023
Benzinga Insights
Tuesday, August 01, 2023
Marijuana Stock Movers For August 1, 2023
Benzinga Insights
MediPharm Delivers Cannabis Clinical Trial Material To US Research Partner And Provides Update On FDA Status
Vuk Zdinjak
Tuesday, July 25, 2023
Cannabis Stock Gainers And Losers From July 25, 2023
Benzinga Insights
Monday, July 24, 2023
Cannabis Stock Movers For July 24, 2023
Benzinga Insights
Thursday, July 20, 2023
Cannabis Stock Movers For July 20, 2023
Benzinga Insights
Wednesday, July 05, 2023
Leadership Shake-Ups Across Several Weed Companies: Who Got The Top Jobs?
Jelena Martinovic
Monday, June 26, 2023
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
Vuk Zdinjak
Monday, May 15, 2023
MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA
Joana Scopel
Thursday, April 13, 2023
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
Vuk Zdinjak
Friday, March 31, 2023
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
Vuk Zdinjak
Tuesday, March 28, 2023
VIVO Cannabis FY22 Revenue Stagnates, What About Net Loss?
Vuk Zdinjak
Wednesday, March 22, 2023
MediPharm Labs Shareholders Approve Merger With VIVO Cannabis
Vuk Zdinjak
Tuesday, March 21, 2023
Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit
Jelena Martinovic
Thursday, December 22, 2022
MediPharm Labs To Acquire VIVO Cannabis
Vuk Zdinjak
Monday, November 14, 2022
MediPharm Touts Strong Q3 Revenue Growth, Continues To Expand Internationally
Jelena Martinovic
Monday, August 15, 2022
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
Vuk Zdinjak
Tuesday, August 09, 2022
MediPharm Labs Enters Cannabis Research Agree...
Benzinga Newsdesk
Wednesday, July 27, 2022
MediPharm Labs Awarded Payment Of $9.8M By Ontario Court Of Justice
Vuk Zdinjak
Monday, July 11, 2022
MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
Vuk Zdinjak
Tuesday, June 14, 2022
BREAKING: Brazil Supreme Court Authorizes Citizens To Grow Medicinal Cannabis
Nicolás Jose Rodriguez
Monday, May 16, 2022
MediPharm Labs Q1 Revenue Slightly Drops, Here Are The Details
Vuk Zdinjak
Show More
